A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by ...

Scientists have been studying Parkinson’s for many years, but they still don’t fully understand why it happens. Without ...

Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

The reluctant decision by Morten Harket, lead singer in the legendary Norwegian band a-ha, to go public with his Parkinson’s ...

UniSA PhD candidate Deepa Nakmode and Professor Sanjay Garg in the lab.A new weekly injectable drug could transform the lives ...

Chinese scientists have discovered subtle new earlier signs of Parkinson’s in mice, an advance that may help diagnose the ...

Parkinson’s Disease is a progressive neurological disorder that will eventually lead to a late or end‑stage with severe ...

Parkinson's disease is a medical condition that causes tremors, difficulty with mobility, and cognitive challenges. It is typically diagnosed later in life, with 60 being the average age of diagnosis.

Parkinson’s disease generally affects people who are over 60 years old. Early-onset Parkinson’s disease is defined as beginning before age 50. The prevalence of Parkinson’s disease increases with ...

Parkinson’s disease involves a small, dark-tinged portion of the brain called the substantia nigra. This is where you produce most of the dopamine your brain uses. Dopamine is the chemical messenger ...

Parkinson disease is most common in people who are older than age 50. The average age at which it occurs is 60. But some younger people may also get Parkinson disease. When it affects someone younger ...

Parkinson’s disease is a chronic disorder in which part of the brain is damaged. This occurs over a long-term period and mainly affects how muscle movement is coordinated. The onset of Parkinson’s ...